Global $10+ Billion Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight, 2026

    NEXT STORY
    Zai Lab Announces First Patients Treated in Separate Phase 1b and Registrational Bridging Studies
    PREV STORY
    ContraFect Announces One-for-Ten Reverse Stock Split
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

    author_avatar
    NASDAQ Market News

    electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults

    author_avatar
    NASDAQ Market News

    Histogenics Corporation to Report Third Quarter 2017 Financial Results on November 9, 2017

    WALTHAM, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leading cell ...

    author_avatar
    NASDAQ Market News